Pediatric Patients with Myocarditis: 7 Case Studies
Pediatric Patients with Myocarditis: 7 Case Studies
Posts
Care and Outcomes and Preliminary Myocarditis and Pericarditis Cases Reported to VAERS after Vaccination in Person less than 29 Years
Care and Outcomes and Preliminary Myocarditis and Pericarditis Cases Reported to VAERS after Vaccination in Person less than 29 Years
The Safety of COVID-19 Vaccinations—We Should Rethink the Policy
The Safety of COVID-19 Vaccinations—We Should Rethink the Policy Harald Walach 1,2,3,*, Rainer J. Klement 4 and Wouter Aukema 5 Citation: Walach,H.;Klement,R.J.; Aukema, W. The Safety of COVID-19 Vaccinations—We Should Rethink the Policy.Vaccines2021,9,693. https:// doi.org/10.3390/vaccines9070693 Academic Editor: Ralph J. DiClemente Received: 2 June 2021 Accepted: 21 June 2021 Published: 24 June 2021 Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affil- iations. Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). 1 2 3 4 Abstract: Background: COVID-19 vaccines have had expedited reviews without sufficient safety data. We wanted to compare risks and benefits. Method: We calculated the number needed to vaccinate (NNTV) from a l...
Salk researchers and collaborators show how the protein damages cells, confirming COVID-19 as a primarily vascular disease
From Salk.Edu https://www.salk.edu/news-release/the-novel-coronavirus-spike-protein-plays-additional-key-role-in-illness/ The novel coronavirus’ spike protein plays additional key role in illness Salk researchers and collaborators show how the protein damages cells, confirming COVID-19 as a primarily vascular disease LA JOLLA—Scientists have known for a while that SARS-CoV-2’s distinctive “spike” proteins help the virus infect its host by latching on to healthy cells. Now, a major new study shows that the virus spike proteins (which behave very differently than those safely encoded by vaccines) also play a key role in the disease itself. The paper, published on April 30, 2021, in Circulation Research, also shows conclusively that COVID-19 is a vascular disease, demonstrating exactly how the SARS-CoV-2 virus damages and attacks the vascular system on a cellular level. The findings help explain COVID-19’s wide variety of seemingly unconnected complications, and could open the door f...
Immunity acquired via infection is much broader than that triggered by current vaccines
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs https://www.cell.com/cell/fulltext/S0092-8674(21)00701-7?fbclid=IwAR3A7M7Z7YvjSQxHFd0gA1fm1xlXgNPSk-LqotuelzU2aAVjmid-8xRjYLU
Liquid Nanoparticles Accumulating in Spleen, Liver, Ovaries and Testes from Pfizer Study
Here is the link to the files. Overview of Pfizers Pharmacokinetic Test https://files.catbox.moe/0vwcmj.pdf
Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients
Abstract SARS-CoV-2 proteins were measured in longitudinal plasma samples collected from 13 participants who received two doses of mRNA-1273 vaccine. 11 of 13 participants showed detectable levels of SARS-CoV-2 protein as early as day one after first vaccine injection. Clearance of detectable SARS-CoV-2 protein correlated with production of IgG and IgA. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab465/6279075?fbclid=IwAR22xjnzsC0ayKSA5Z63CReAXzK2Od0M8P0Rx-Yq6n3Pwteopl0amqU1G-o Q. Do Vaccines Disappear in Body after 2-3 Days? A. This submitted and accepted paper shows at least 30 days Q. Is this a big study A. No Only 13 people. Things to note: S1 antigen was detected as early as day one post vaccination and peak levels were detected on average five days after the first injection. For one individual (Participant #8), spike was detected at day 29, one day after the second injection and was undetec...